Lemborexant Completed Phase 1 Trials for CNS Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT016734512-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects